DEIDRE MILLS: Open Payments
NPI 1720464225 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,028 in 59 payments from 19 companies in 2025. Trend: 2023 $779 · 2024 $1,314 · 2025 $1,028
Food & beverage: $1,020Education: $8
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 16 | $212 |
| Lilly USA, LLC | 11 | $134 |
| Radius Health, Inc. | 4 | $113 |
| Dexcom, Inc. | 4 | $73 |
| Abbott Laboratories | 3 | $56 |
| SANOFI-AVENTIS U.S. LLC | 3 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $54 |
| Rhythm Pharmaceuticals, Inc. | 2 | $49 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $45 |
| Tandem Diabetes Care, Inc. | 2 | $37 |
Products named: TEPEZZA, Tymlos, JARDIANCE, Dexcom G6 Transmitter, MOUNJARO, FREESTYLE LIBRE 3, TZIELD, IMCIVREE.
Industry payments across GA — which companies pay providers there.
